Screener
Bausch Health Companies BHC Q3 2026 earnings
Reported October 28, 2026 · After market close
Revenue$2.9BBeat by $162.4M
EPS$1.77Beat by $0.52
Revenue estimate$2.7B
EPS estimate$1.25
“Bausch Health, excluding Bausch + Lomb, delivered another solid quarter, marking fourteen consecutive quarters of year-over-year Revenue and Adjusted EBITDA growth. We also achieved an important milestone, with quarterly Adjusted EBITDA, excluding Bausch + Lomb, exceeding $1 billion for the first time. Our performance reflects disciplined execution across the portfolio, with healthy cash generation supporting more than $500 million of net debt reduction during the quarter. These results give us confidence to again raise our full year 2026 guidance. We remain focused on operational excellence, sustainable growth, and long-term value creation”
Next report
Date not yet announcedValuation & ratios
Segments
By segment
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Bausch Health Companies report Q3 2026 earnings?
- Bausch Health Companies (BHC) reported Q3 2026 earnings on October 28, 2026 after market close.
- What were Bausch Health Companies's Q3 2026 revenue and EPS?
- Bausch Health Companies reported revenue of $2.9B and eps of $1.77 for Q3 2026.
- Did Bausch Health Companies beat estimates in Q3 2026?
- Revenue beat the consensus estimate of $2.7B by $162.4M. EPS beat the consensus estimate of $1.25 by $0.52.
- How did Bausch Health Companies's Q3 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 7.7% from $2.7B a year earlier and eps grew 52.6% from $1.16.
- Where can I find Bausch Health Companies's Q3 2026 SEC filings?
- You can read the 8-K earnings release (0000885590-26-000121) and the 10-Q periodic report (0000885590-26-000123) directly on SEC EDGAR. The filing index links above go to sec.gov.
